Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Science Corporation, formerly Neuralink, has implanted its vision-restoring chip in its first patient with Stargardt disease. Max Hodak, the company's former president and co-founder, discussed the development at TechCrunch Disrupt. The implant is part of Science Corporation's work on a brain-computer interface (BCI), specifically in collaboration with PRIMA.